SE368828B - - Google Patents

Info

Publication number
SE368828B
SE368828B SE11891/71A SE1189171A SE368828B SE 368828 B SE368828 B SE 368828B SE 11891/71 A SE11891/71 A SE 11891/71A SE 1189171 A SE1189171 A SE 1189171A SE 368828 B SE368828 B SE 368828B
Authority
SE
Sweden
Application number
SE11891/71A
Inventor
R Boesch
Original Assignee
Rhone Poulenc Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7034133A external-priority patent/FR2105060A1/fr
Priority claimed from FR7130825A external-priority patent/FR2150236A2/fr
Application filed by Rhone Poulenc Sa filed Critical Rhone Poulenc Sa
Priority to US00265014A priority Critical patent/US3777280A/en
Publication of SE368828B publication Critical patent/SE368828B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE11891/71A 1970-09-21 1971-09-20 SE368828B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US00265014A US3777280A (en) 1971-09-20 1972-07-21 Laser generator of te wave guide modes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7034133A FR2105060A1 (en) 1970-09-21 1970-09-21 Anthelmintic imidazo (4,5-b) pyridine derivs - with low mammalian toxicity,for oral human and veterinary use
FR7130825A FR2150236A2 (en) 1971-08-25 1971-08-25 Anthelmintic imidazo (4,5-b) pyridine derivs - with low mammalian toxicity,for oral human and veterinary use

Publications (1)

Publication Number Publication Date
SE368828B true SE368828B (de) 1974-07-22

Family

ID=26215952

Family Applications (1)

Application Number Title Priority Date Filing Date
SE11891/71A SE368828B (de) 1970-09-21 1971-09-20

Country Status (13)

Country Link
AU (1) AU453067B2 (de)
BE (1) BE772835A (de)
CA (1) CA940131A (de)
CH (1) CH532600A (de)
DE (1) DE2147103C3 (de)
DK (1) DK131345B (de)
ES (2) ES395260A1 (de)
GB (1) GB1318859A (de)
HU (1) HU163150B (de)
IL (1) IL37752A (de)
LU (1) LU63927A1 (de)
NL (1) NL145553B (de)
SE (1) SE368828B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU763431B2 (en) 1999-03-31 2003-07-24 Uaf Technologies And Research Llc Viral treatment
US6593466B1 (en) 1999-07-07 2003-07-15 Isis Pharmaceuticals, Inc. Guanidinium functionalized nucleotides and precursors thereof
US6384049B1 (en) 2000-05-25 2002-05-07 The Procter & Gamble Company Cancer treatment

Also Published As

Publication number Publication date
CA940131A (en) 1974-01-15
ES403910A1 (es) 1975-05-01
GB1318859A (en) 1973-05-31
AU453067B2 (en) 1974-09-19
HU163150B (de) 1973-06-28
ES395260A1 (es) 1973-12-01
NL7112971A (de) 1972-03-23
NL145553B (nl) 1975-04-15
DE2147103A1 (de) 1972-03-23
DK131345C (de) 1975-11-24
AU3373571A (en) 1973-03-29
DE2147103C3 (de) 1975-07-17
DE2147103B2 (de) 1974-11-14
IL37752A0 (en) 1971-11-29
IL37752A (en) 1974-10-22
LU63927A1 (de) 1972-06-27
DK131345B (da) 1975-06-30
BE772835A (fr) 1972-03-20
CH532600A (fr) 1973-01-15

Similar Documents

Publication Publication Date Title
DK131345C (de)
AU1146470A (de)
AU1473870A (de)
FR2105060B1 (de)
AU1833270A (de)
AU1326870A (de)
AU1716970A (de)
AU1336970A (de)
AU1517670A (de)
AU2144270A (de)
AU1235770A (de)
AU1581370A (de)
AU1086670A (de)
AU1872870A (de)
AU1189670A (de)
AU1591370A (de)
AU1247570A (de)
AU1603270A (de)
AU1343870A (de)
AU1689770A (de)
AU1277070A (de)
AU1328670A (de)
AU1789870A (de)
AU1832970A (de)
AU1841070A (de)